Abstract:Highlights • Identifying the XO inhibitory inhibition of crude extract and fractions. • Eighteen potential XO compounds were isolated and elucidated. • Six XO inhibitors from D. spathacea were identified. • The potency XO inhibitors interact with active site and molybdopterin center of XO. Xanthine oxidase (XO) has been widely recognized as a pivotal enzyme in developing hyperuricemia, primarily contributing to the excessive production of uric acid during purine metabolism in the liver. One of the standard treatment approaches involves reducing uric acid levels by inhibiting XO activity. In this study, the leaf extract of Dolichandrone spathacea , traditionally used in folk medicine, was found to inhibit XO activity in the ethyl acetate and butanol fractions at a concentration of 100 μg/mL, their values were 78.57 ± 3.85 % (IC 50 = 55.93 ± 5.73 μg/ml) and 69.43 ± 8.68 % (IC 50 = 70.17 ± 7.98 μg/ml), respectively. The potential XO inhibitory components were isolated by bioactivity assays and the HR-ESI-MS and NMR spectra system. The main constituents of leaf extracts of Dolichandrone spathacea , six compounds, namely trans- 4-methoxycinnamic acid ( 3 ), trans -3,4-dimethoxycinnamic acid ( 4 ), p -coumaric acid ( 5 ), martynoside ( 6 ), 6-O-( p -methoxy- E -cinnamoyl)-ajugol ( 7 ), and scolymoside ( 17 ), were identified as potent XO inhibitors with IC 50 values ranging from 19.34 ± 1.63 μM to 64.50 ± 0.94 μM. The enzyme kinetics indicated that compounds 3 – 5 , 7 , and 17 displayed competitive inhibition like allopurinol, while compound 6 displayed a mixed-type inhibition. Computational studies corroborated these experimental results, highlighting the interactions between potential metabolites and XO enzyme. The hydrogen bonds played crucial roles in the binding interaction, especially, scolymoside ( 17 ) forms a hydrogen bond with Mos3004, exhibited the lowest binding energy (−18.3286 kcal/mol) corresponding to the lowest IC 50 (19.34 ± 1.63 μM). Furthermore, nine compounds were isolated for the first time from this plant. In conclusion , Dolichandrone spathacea and its constituents possess the potential to modulate the xanthine oxidase enzyme involved in metabolism.

<p>Novel potential XOD inhibitory peptides derived from Trachinotus ovatus: Isolation, identification and structure-function analysis</p>

Identification of Novel Antioxidant Peptide from Porcine Plasma Hydrolysate and Its Effect in in Vitro Digestion/hepg2 Cells Model

Novel hemoglobin-derived xanthine oxidase inhibitory peptides: Enzymatic preparation and inhibition mechanisms

Identification of a New Antioxidant Peptide from Porcine Plasma by in Vitro Digestion and Its Cytoprotective Effect on H2O2 Induced HepG2 Model

Exploration, Sequence Optimization and Mechanism Analysis of Novel Xanthine Oxidase Inhibitory Peptide from Ostrea Rivularis Gould.

Xanthine Oxidase Inhibitory Peptides from Larimichthys polyactis: Characterization and In Vitro/In Silico Evidence

Novel Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein: Identification, in Vitro Inhibition Mechanism and in Vivo Activity Validation

Separation, Identification and Docking Analysis of Xanthine Oxidase Inhibitory Peptides from Pacific Cod Bone-Flesh Mixture

In Vivo Anti-Hyperuricemic and Xanthine Oxidase Inhibitory Properties of Tuna Protein Hydrolysates and Its Isolated Fractions.

Antihyperuricemic Activity and Inhibition Mechanism of Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein by Virtual Screening.

Exploring the potential of novel xanthine oxidase inhibitory peptide (ACECD) derived from Skipjack tuna hydrolysates using affinity-ultrafiltration coupled with HPLC-MALDI-TOF/TOF-MS.

Systematic investigation of the amino acid profiles that are correlated with xanthine oxidase inhibitory activity: Effects, mechanism and applications in protein source screening

Antidiabetic effects of protein hydrolysates from Trachinotus ovatus and identification and screening of peptides with α-amylase and DPP-IV inhibitory activities

Using deep learning and molecular dynamics simulations to unravel the regulation mechanism of peptides as noncompetitive inhibitor of xanthine oxidase

Identification, Inhibitory Mechanism and Transepithelial Transport of Xanthine Oxidase Inhibitory Peptides from Whey Protein after Simulated Gastrointestinal Digestion and Intestinal Absorption

A possible covalent xanthine oxidase inhibitor TS10: Inhibition mechanism, metabolites identification and PDPK assessment

Purification and Identification of Xanthine Oxidase Inhibitory Peptides from Enzymatic Hydrolysate of Α-Lactalbumin and Bovine Colostrum Casein.

Identification and Anti-Hyperuricemic Activity of Xanthine Oxidase Inhibitory Peptides from Pacific White Shrimp and Swimming Crab Based on Molecular Docking Screening.

Tryptophan Residue Enhances in Vitro Walnut Protein-Derived Peptides Exerting Xanthine Oxidase Inhibition and Antioxidant Activities

Xanthine oxidase inhibition study of isolated secondary metabolites from Dolichandrone spathacea (Bignoniaceae): In vitro and in silico approach

Virtual Screening and Structure Optimization of Xanthine Oxidase Inhibitory Peptides from Whole Protein Sequences of Pacific White Shrimp Via Molecular Docking